Trial intelligence / Profile preview

Lumason/SonoVue in Dobutamine Stress Echocardiography for Diagnosis of Coronary Artery Disease

2015-001962-25Phase 3Completed

Sponsor
Bracco Imaging
Start
Oct 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of sulfur hexafluoride in coronary arteriosclerosis, sponsored by Bracco Imaging. Started Oct 2015; status: completed.

02

Drugs

sulfur hexafluoride
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on 2015-001962-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-001962-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call